DYLAN KOENIG: Open Payments
NPI 1780156232 · MUNISING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 47 payments from 14 companies in 2025. Trend: 2023 $1,025 · 2024 $964 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $321 |
| PFIZER INC. | 5 | $92 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Exact Sciences Corporation | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $30 |
Products named: QULIPTA, VRAYLAR, NURTEC ODT, TRELEGY ELLIPTA, CAPLYTA, The Cologuard Plus Collection Kit, JARDIANCE, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
